Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2021
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2020
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [3]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NMD Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Zero Leprosy Toolkit
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Organizations

Refine your results

Refine your results


NTD

  • Leprosy (Hansen disease) (46)
  • Trachoma (9)
  • Lymphatic filariasis (Elephantiasis) (8)
  • Buruli Ulcer (7)
  • Onchocerciasis (6)
  • Schistosomiasis (4)
  • Soil-transmitted helminths (4)
  • Leishmaniasis (3)
  • Yaws (1)

Country

  • United States (6)
  • Nigeria (5)
  • Tanzania (5)
  • United Kingdom (5)
  • Netherlands (4)
  • Switzerland (4)
  • Mozambique (3)
  • Canada (2)
  • Ethiopia (2)
  • France (2)
  • Kenya (2)
  • Portugal (2)
  • Spain (2)
  • Australia (1)
  • Belgium (1)
  • Botswana (1)
  • Burkina Faso (1)
  • Cameroon (1)
  • Congo - Brazzaville (1)
  • Germany (1)
  • Ghana (1)
  • Italy (1)
  • Mali (1)
  • New Zealand (1)
  • Niger (1)
  • Uganda (1)

Type of Organization

  • NGO (156)
  • Academic/reseach institution (57)
  • Partnership (35)
  • NTD NGDO Network member (30)
  • Government department/organization (24)
  • People's organization (21)
  • Training/education (19)
  • Information, library and publishing (16)
  • Hospital/clinic (13)
  • ILEP member (12)
  • Archive/museum (10)
  • InfoNTD Partner (10)
  • Infolep Partner (9)
  • Professional organization (8)
  • Commercial organization/private business (4)
  • Funding & Grants (3)
  • Religious organization (3)
 
64 items
Organization

AIFO - Associazione Italiana Amici di Raoul Follereau

Organization

ALEMO - Mozambique Association of Persons with Leprosy

Organization

APARF - Associação Portuguesa Amigos de Raoul Follereau

Organization

Association IDEA Niger

Organization

ESPEN - Expanded Special Project for Elimination of Neglected Tropical Diseases

Organization

Eye Care Foundation

Organization

Fontilles

Organization

IDEA Mocambique

Organization

IDEA Nigeria

Organization

National Leprosy, Yaws, Leishmaniasis and Buruli Ulcer Control Programme - Ministry of Public Health Cameroon

Organization

SLC - Secours aux Lépreux - Leprosy Relief Canada

Organization

TDR - Special Programme for Research and Training in Tropical Diseases

Organization

TLM England and Wales - The Leprosy Mission England and Wales

Organization

The Task Force for Global Health

Organization

AHRI - Armauer Hansen Research Institute

Organization

COUNTDOWN - Calling time on Neglected Tropical Diseases

Organization

Evangelische Lepra-Mission / Mission Évangélique contre la lèpre

Organization

HKI - Helen Keller International

Organization

LTR - Leprosy and TB Relief Initiative Nigeria

Organization

Lepra

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page ›› ›
  • Last page Last » »

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • About Infolep
  • Privacy statement
  • FAQ
  • Contact

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2021 Infolep